Agnieszka Bartoszewicz

Title: Agnieszka Bartoszewicz: Innovator in Chitinase Inhibitors

Introduction

Agnieszka Bartoszewicz is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of biochemistry, particularly in the development of chitinase inhibitors. With a total of 5 patents to her name, her work has the potential to impact various therapeutic applications.

Latest Patents

Agnieszka's latest patents include innovative approaches to targeting the chitinase-like protein YKL-40. One of her notable inventions involves assays for screening active compounds that interfere with the interaction between YKL-40 and chitin oligomers, as well as heparan sulfate. This research not only identifies active compounds as inhibitors of YKL-40 but also explores their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. Another significant patent focuses on substituted amino triazoles, which are useful as chitinase inhibitors. These compounds are designed to treat various conditions, including asthma reactions, inflammatory diseases, autoimmune diseases, and even cancer.

Career Highlights

Agnieszka has worked with notable companies such as Oncoarendi Therapeutics S.A. and Molecure S.A. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Throughout her career, Agnieszka has collaborated with talented individuals, including Marzena Mazur and Robert Koralewski. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Agnieszka Bartoszewicz is a remarkable inventor whose work in chitinase inhibitors holds promise for various therapeutic applications. Her contributions to the field continue to pave the way for innovative solutions in medicine.